Blockers of the Kv1.3 channel, a voltage-gated K+ channel found in human T-
cells, have recently been recognised as a general strategy for immunosuppre
ssion. These blockers are divided into two classes - peptidyl and non-pepti
dyl Kv1.3 channel blockers. This article covers the patents filed for Kv1.3
channel blockers dating from 1996 to the first quarter of 2000.